# Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5

> **NCT00743353** · EARLY_PHASE1 · COMPLETED · sponsor: **Siemens Molecular Imaging** · enrollment: 16 (estimated)

## Conditions studied

- Sarcoma
- Melanoma
- Lung Cancer
- Breast Cancer
- High Grade Gliomas

## Interventions

- **DRUG:** F-18 RGD-K5

## Key facts

- **NCT ID:** NCT00743353
- **Lead sponsor:** Siemens Molecular Imaging
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2009-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00743353

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00743353, "Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00743353. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*